The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors. The company did not immediately respond to a Reuters request for comment ...
The FDA has approved the first systemic therapy for patients with NSCLC or pancreatic adenocarcinoma with an NRG1 gene fusion.
The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...
Enrollment in cohort 5 of the phase 1/2 GOBLET study will resume after the Data Safety Monitoring Board’s safety review.
Breast, bladder, and pancreatic cancers are increasingly being treated with a broad range of therapies before a patient ...
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
Function Health, a lab tests startup, announced today that its members will now have access to early cancer detection tests ...
Oncosil Medical's investors have been promised a “catalyst rich” 2025 and 2026, including expected filings to the local TGA ...
Stroud pancreatic cancer survivor, Bryony Thomas is calling on the Government to urgently address shortages of a medication ...